Access expired on Saturday, August 19, 2017
This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.
Already Have An Account? Log in Now
Sequential Ipilimumab Monotherapy vs Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Sequential Ipilimumab Monotherapy vs Best Supportive Care For Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
Clin. Cancer Res 2017 Jun 27;[EPub Ahead of Print], YJ Bang, JY Cho, YH Kim, JW Kim, M Di Bartolomeo, JA Ajani, K Yamaguchi, A Balogh, T Sanchez, M MoehlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.